Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383–390

Antzeko izenburuak

• Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
  nork: Niewczas, Monika A., et al.
  Argitaratua: (2017)
• Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777–783
  nork: Lachin, John M., et al.
  Argitaratua: (2017)
• Response to Comment on Jaiswal et al. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care 2017;40:1226–1232
  nork: Jaiswal, Mamta, et al.
  Argitaratua: (2018)
• Risk for ESRD in Type 1 Diabetes Remains High Despite Renoprotection
  nork: Rosolowsky, Elizabeth T., et al.
  Argitaratua: (2011)
• Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418
  nork: Solomon, Sharon D., et al.
  Argitaratua: (2017)